Clinical Trial

Parasternal Blockade and Serum Lactate in Cardiac Surgery

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06516432
Lead Sponsor Instituto Mexicano del Seguro Social
Conditions Elective Cardiac Surgery
Enrollment 86 participants
Start Date 2024-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-24